| Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders L M Valor, J Viosca, J P Lopez-Atalaya, A Barco Current pharmaceutical design 19 (28), 5051-5064, 2013 | 168 | 2013 |
| Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability LM Valor, MM Pulopulos, M Jimenez-Minchan, R Olivares, B Lutz, ... Journal of Neuroscience 31 (5), 1652-1663, 2011 | 143 | 2011 |
| cAMP response element-binding protein is a primary hub of activity-driven neuronal gene expression E Benito, LM Valor, M Jimenez-Minchan, W Huber, A Barco Journal of neuroscience 31 (50), 18237-18250, 2011 | 121 | 2011 |
| CBP is required for environmental enrichment‐induced neurogenesis and cognitive enhancement JP Lopez‐Atalaya, A Ciccarelli, J Viosca, LM Valor, M Jimenez‐Minchan, ... The EMBO journal 30 (20), 4287-4298, 2011 | 121 | 2011 |
| Inhibition of cAMP response element-binding protein reduces neuronal excitability and plasticity, and triggers neurodegeneration D Jancic, M Lopez de Armentia, LM Valor, R Olivares, A Barco Cerebral cortex 19 (11), 2535-2547, 2009 | 115 | 2009 |
| Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition JP Lopez-Atalaya, S Ito, LM Valor, E Benito, A Barco Nucleic acids research 41 (17), 8072-8084, 2013 | 110 | 2013 |
| Transcription, epigenetics and ameliorative strategies in Huntington’s Disease: a genome-wide perspective LM Valor Molecular neurobiology 51, 406-423, 2015 | 107 | 2015 |
| Effects of ginsenoside Rg2 on human neuronal nicotinic acetylcholine receptors F Sala, J Mulet, S Choi, SY Jung, SY Nah, H Rhim, LM Valor, M Criado, ... Journal of Pharmacology and Experimental Therapeutics 301 (3), 1052-1059, 2002 | 94 | 2002 |
| Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease LM Valor, D Guiretti, JP Lopez-Atalaya, A Barco Journal of Neuroscience 33 (25), 10471-10482, 2013 | 82 | 2013 |
| Potentiation of human α4β2 neuronal nicotinic receptors by a Flustra foliacea metabolite F Sala, J Mulet, KP Reddy, JA Bernal, P Wikman, LM Valor, L Peters, ... Neuroscience letters 373 (2), 144-149, 2005 | 78 | 2005 |
| International consensus recommendations on the diagnostic work-up for malformations of cortical development R Oegema, TS Barakat, M Wilke, K Stouffs, D Amrom, E Aronica, ... Nature Reviews Neurology 16 (11), 618-635, 2020 | 72 | 2020 |
| Effects of ginsenosides, active components of ginseng, on nicotinic acetylcholine receptors expressed in Xenopus oocytes S Choi, SY Jung, JH Lee, F Sala, M Criado, J Mulet, LM Valor, S Sala, ... European journal of pharmacology 442 (1-2), 37-45, 2002 | 68 | 2002 |
| Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: pharmacological and molecular evidence of orexin involvement M Alcaraz-Iborra, F Carvajal, JM Lerma-Cabrera, LM Valor, I Cubero Behavioural brain research 272, 93-99, 2014 | 64 | 2014 |
| Kinase networks integrate profiles of N-methyl-D-aspartate receptor-mediated gene expression in hippocampus MP Coba, LM Valor, MV Kopanitsa, NO Afinowi, SGN Grant Journal of Biological Chemistry 283 (49), 34101-34107, 2008 | 60 | 2008 |
| What's wrong with epigenetics in Huntington's disease? LM Valor, D Guiretti Neuropharmacology 80, 103-114, 2014 | 58 | 2014 |
| Early alteration of epigenetic-related transcription in Huntington’s disease mouse models I Hervás-Corpión, D Guiretti, M Alcaraz-Iborra, R Olivares, ... Scientific reports 8 (1), 9925, 2018 | 46 | 2018 |
| CREB regulates distinct adaptive transcriptional programs in astrocytes and neurons L Pardo, LM Valor, A Eraso-Pichot, A Barco, A Golbano, GE Hardingham, ... Scientific reports 7 (1), 6390, 2017 | 46 | 2017 |
| Role of the large cytoplasmic loop of the α7 neuronal nicotinic acetylcholine receptor subunit in receptor expression and function LM Valor, J Mulet, F Sala, S Sala, JJ Ballesta, M Criado Biochemistry 41 (25), 7931-7938, 2002 | 46 | 2002 |
| Epigenetic factors in intellectual disability: the Rubinstein–Taybi syndrome as a paradigm of neurodevelopmental disorder with epigenetic origin JP Lopez-Atalaya, LM Valor, A Barco Progress in molecular biology and translational science 128, 139-176, 2014 | 44 | 2014 |
| Multiple functional Sp1 domains in the minimal promoter region of the neuronal nicotinic receptor α5 subunit gene A Campos-Caro, C Carrasco-Serrano, LM Valor, S Viniegra, JJ Ballesta, ... Journal of Biological Chemistry 274 (8), 4693-4701, 1999 | 43 | 1999 |
